Chinese Life Sciences Visit – 4 July 1 Victoria St Conference Centre, London

The Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) is bringing a delegation to the UK in July, as part of their co-operation with UKTI under the Joint Economic Trade Commission Healthcare Working Group. This event will give you the opportunity to find out more about how CCCMHPIE, UKTI and the China-Britain Business Council (CBBC) can help UK companies doing business in China, and network with the delegation of Chinese Life Sciences companies.

Places are limited at this event, to confirm a place, email – [email protected] providing a short paragraph about your company by 27 June.

Time Agenda

10.30 – 11:00 Registration Introductory presentations from Dr Mark 11.00 - 11.20 Treherne, UKTI and Madam MENG Dongping, CCCMHPIE 11:20 -11:40 Presentations from the Chinese delegation

11:40 -11:50 Case study

11:50 -12:00 Closing remarks

12:00 -14:00 Networking and Lunch

Chinese Delegation

Name Organisation Title

ZHOU Xiaoming Chinese Embassy in the UK Minister Commercial Counsellor

MENG CCCMHPIE, Vice President – Dongping under MOFCOM Lead of the Delegation

State Administration of Traditional Chinese Medicine of the People's Republic of China Vice Director-General WU Zhendou (SATCM) Ministry of Commerce of the People's Republic of China Deputy Director YU Miao (MOFCOM) CCCMHPIE, Department of GUO Xiaodan under MOFCOM Pharmaceuticals ZHANG Li CCCMHPIE, Department of Law Affairs (Ally) under MFOCOM of Strategic Planning Institute of Chinese Materia Medica of China Academy of LIJianrong Chinese Medical Sciences Researcher Institute of Chinese Materia Medica of China Academy of LIANG Aihua Chinese Medical Sciences Researcher China Tongrentang LI Xia (Group) Co.,Ltd. Chief Engineer China Beijing Tongrentang FENG Li (Group) Co.,Ltd. Assistant to the President JIANG Xiaoyue Zhejiang Medicines Co.,Ltd. Director in Chief Director of the Department HE Yimin Zhejiang Medicines Co.,Ltd. of International Trade

DAI Biao Group CEO

Beijing Holley-Cotec Chief Director of MU Zexun Pharmaceuticals Co., Ltd. International Marketing Orient International Holding Shanghai Rongheng International Trading Co., WANG Huijuan Ltd General Manager Yangtze River Head of the International XIE Li Pharmaceutical Group Department North China Pharmaceutical WANG Lihong Group Corporation Chief Director of Marketing Youcare Pharmaceutical HE Yingjun Group Co.Ltd Vice General Manager

Company Information

China Chamber of Commerce for Imp.& Exp. of Medicines and Health Products Founded in May 1989, China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), is the leading and most influential national trade association in China with a mission to promote the international trade and cooperation in medicinal and health products. CCCMHPIE is directly under the Ministry of Commerce of China, has a diverse membership of more than 2,400 companies including most of the major manufacturers and trading companies of pharmaceutical and health products across China.

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences The Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences is one of the oldest national institutions specially engaged in the research of Chinese materia medica in China. At present, there are more than 136 on-going research projects. Since the foundation of the institute, 18 projects have been awarded national prizes, 57 projects awarded ministerial and bureau prizes and 172 projects awarded academic prizes. To date, the institute has developed 32 new medicines. In 2011, Professor TU You, was honored the Lasker~DeBakey Clinical Medical Research Award of U.S.A. for her outstanding contribution offered during the development of artemisinin.

Tasly Group Co.,Ltd. Incorporated in 1994 with a registered capital of CNY240 million, Tasly Group currently controls over 50 subsidiaries and branches with a staff of 13,000. The group a network of more than 30 countries and regions and has 22 branches and 3 representative offices worldwide. In 2012 Tasly achieved sales of CNY21.3 billion, in which $68.8 million was obtained overseas.

Yangtze River Pharmaceutical (Group) Co., Ltd. Yangtze River Pharmaceutical Group (hereinafter refers to as YRPG) was founded in 1971, with over 9000 employees and a total floor area of over 2 million square meters. YRPG is a cross-region pharmaceutical group, integrated with science and technology, industry and trading, combining production, learning and research. YRPG has been ranked in the top 5 of national pharmaceutical industry for over 10 years. YRPG was ranked top 1 in China Pharmaceutical Industry Top 100 which was issued by the Ministry of Industry and Information Technology (MIIT) in 2009 and 2010.

Zhejiang Medicine Co., Ltd. Zhejiang Medicine Co., Ltd. (hereinafter refers to as ZMC) is a manufacturer and supplier of pharmaceutical, human and animal nutrition products. ZMC Xinchang Pharma employs 3,300 people operating a 500,000m2 manufacturing facility, and maintains assets of USD 568 million. 2009 revenue was USD 448 million. ZMC Xinchang Pharma manufactures and supplies a broad product line specializing in fat soluble vitamins, carotenoids, active pharmaceutical ingredients (APIs) through both synthetic process and fermentation.

China Beijing Group Co.,Ltd In 1992, Beijing Tong Ren Tang Group Co., Ltd was established which became a solely state-owned company duly authorized by Beijing Municipal Government to run national assets in 2001. The company registered capital was 235.44 million yuan. It has owned more than 1500 products, 83 production lines passing domestic and foreign GMP certification and over 1500 retail terminals. Beijing TRT has 84 pharmacies in 16 foreign countries and regions.

Orient Int’L Holding, Shanghai Rongheng Int’L Trading Co., Ltd. Founded in 1992, OIH Shanghai Rongheng specializes in healthcare products, mainly in marketing Generics in South-east Asia and African countries, where the official product registrations are required with the drugs authorities. They are involved in the entire process of GMP pre-auditing on Chinese Generics producers, products registrations, marketing plans and promotion. They have a range of products including tablets, capsules, liquid injections, powder for injections, skin screams and ointments, eye ointments, biological products, sutures, surgical blades. They also market surgical disposables in Eastern Europe.

NCPC International Corp. NCPC Group was founded in 1953 and includes 31 affiliates, including API and formulations. For API, many products have CEP and EGMP. For formulation, towards regulated market, we had established two new facility, one is NCPC New Formulation Branch Factory, another is NCPC Hebei Huamin Pharmaceutical Co., Ltd. NCPC New Formulation Branch Factory is the production base for formulation of non-penicillin and non-cephalosporin, covers an area of 388 acres, total investment is RMB 2.6 billion. NCPC Hebei Huamin Pharmaceutical Co., Ltd. is the production base for cephalosporins in NCPC and the largest production base for cephalosporins in China. Covering an area of 388 acres, and the total investment is RMB 1.2 billion.

Beijing Holley-Cotec Pharmaceuticals Co., Ltd Established in 1992, Beijing Holley-Cotec Pharmaceuticals Co., Ltd is one of the leading pharmaceutical companies in the R&D, manufacturing and marketing of anti- malaria in the world. With their brand “Duo-Cotecxin” in Africa and Southeast Asia, they have a good network of distribution and marketing throughout major endemic countries, especially the sub-Sahara areas. With the WHO GMP certified formulation facility in Jiaxing, Zhejiang province, their business plan is to prequalify our Duo- Cotecxin in WHO Geneva in the near future. They are very interested in exploring the possibility of licensing in good products for African market, Chinese market and even for EU market by partnering with medium sized pharmaceuticals company in the EU.

Shanghai Medicines & Health Products Import & Export Co. Ltd. Shanghai Medicines and Health Products Import and Export Co., Ltd. was incorporated in 1986. Their business focus on import and export operations for Medicines and Health Products. Their major business lines include Active Pharmaceutical Ingredients, Medicines, Health Products, Herbal Extracts, Chinese Medicated Herbs, Surgical Dressing, Professional Medical Device, Hospital Appliance, Domestic Healthcare Instrument. Annual turnover is 180-200million USD.